# A Study to Assess the Effects of Multiple Study Drug Regimens in Subjects With Newly Diagnosed Locally Advanced Head and Neck Squamous Cell Carcinoma

> **NCT03818542** · PHASE1 · TERMINATED · sponsor: **AbbVie** · enrollment: 3 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** ABBV-181
- **DRUG:** ABBV-368
- **DRUG:** ABBV-927
- **DRUG:** ABBV-927

## Key facts

- **NCT ID:** NCT03818542
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-22
- **Primary completion:** 2020-09-23
- **Final completion:** 2020-09-23
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Strategic considerations
- **Last updated:** 2020-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03818542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03818542, "A Study to Assess the Effects of Multiple Study Drug Regimens in Subjects With Newly Diagnosed Locally Advanced Head and Neck Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03818542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*